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Available online 27 August 2011Abstract Fibroblast feeder cells play an important role in supporting the derivation and long term culture of undifferentiated, plu-
ripotent human embryonic stem cells (hESCs). The feeder cells secrete various growth factors and extracellularmatrix (ECM) proteins
into extracellular milieu. However, the roles of the feeder cell-secreted factors are largely unclear. Animal feeder cells and use of
animal serum also make current feeder cell culture conditions unsuitable for derivation of clinical grade hESCs. We established
xeno-free feeder cell lines using human serum (HS) and studied their function in hESC culture. While human foreskin fibroblast
(hFF) feeder cells were clearly hESC supportive, none of the established xeno-free human dermal fibroblast (hDF) feeder cells
were able to maintain undifferentiated hESC growth. The two fibroblast types were compared for their ECM protein synthesis, integ-
rin receptor expression profiles and key growth factor secretion. We show that hESC supportive feeder cells produce laminin-511 and
express laminin-binding integrins α3ß1, α6ß1 and α7ß1. These results indicate specific laminin isoforms and integrins in maintenance
of hESC pluripotency in feeder-dependent cultures. In addition, several genes with a known or possible role for hESC pluripotency
were differentially expressed in distinct feeder cells.
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Undifferentiated human embryonic stem cells (hESCs) are tra-
ditionally cultured on mouse embryonic fibroblast (mEF)
feeder cells in either fetal bovine serum (FBS) or serum re-
placement supplemented culture medium (Thomson et al.,
1998; Draper et al., 2004). The exposure of hESCs to reagents
of animal origin is likely to contaminate the cells with animal
pathogens and non-human, immunogenic molecules (Martin
et al., 2005; Heiskanen et al., 2007). Future clinical use of
stem cell based products requires defined, Good Manufactur-
ing Practice (GMP) compatible culture systems that are free
of animal-derived reagents.
There have been two main approaches for replacing mEFs:
the use of human feeder cells and the development of feeder-
independent culture conditions. The feeder-independent cul-
ture systems often rely on the use of Matrigel extracellular
matrix (ECM) preparation and mEF conditioned hESC medium
(CM) (Xu et al., 2001). More defined culture methods based
on human basement membrane protein coatings and serum-
free culture media have been described (Ludwig et al.,
2006a). Many of the feeder-independent culture conditions,
however, are not defined and have been difficult to reproduce
with different hESC lines (Hakala et al., 2009; Akopian et al.,
2010). The derivation of new hESC and human induced plurip-
otent stem cell (hiPSC) lines is still routinely performed on
supportive feeder layers, although there are a few recent
studies describing hESC and hiPSC lines established on ECM
preparations (Ludwig et al., 2006a; Klimanskaya et al., 2005;
Fletcher et al., 2006; Lagarkova et al., 2010; Sun et al., 2009).
Feeder cells play a crucial role in maintaining undifferen-
tiated hESC morphology and pluripotent status in feeder-de-
pendent culture conditions. Human fibroblasts originating
from different sources show varying capacity in supporting
undifferentiated hESC culture. Clearly, the most supportive fi-
broblasts are derived from fetal tissue (Richards et al., 2003;
Genbacev et al., 2005; Chavez et al., 2008; Kumar et al.,
2009; Kibschull et al., 2011). Ethical considerations in using
aborted human fetuses make this tissue source an unattractive
option. We have derived and successfully propagated eight
Regea hESC lines using commercial human foreskin fibroblast
(hFF) (CRL-2429, ATCC) feeder cells (Skottman, 2010; Rajala
et al., 2010). The hFFs have become the most commonly
used human feeder cell type for hESC derivation and culture
(Hovatta et al., 2003; Inzunza et al., 2005; Aguilar-Gallardo
et al., 2010; Strom et al., 2010), and even human dermal fibro-
blasts (hDF) have been used for hESC propagation (Richards
et al., 2003; Tecirlioglu et al., 2010). Skin is an easily accessi-
ble tissue source for derivation of fibroblasts, but there are no-
table differences between the capacities of different
fibroblast lines to support hESC cultures (Eiselleova et al.,
2008). Reasons for this are poorly understood.
The fibroblast feeder cells support hESCs by secreting
growth factors and ECM components to the culture medium
and also by directly interacting with the hESCs through cell–
cell contacts. The factors secreted by fibroblast feeder cells
have been studied by analyzing fibroblast CM (Lim and Bodnar,
2002; Prowse et al., 2005; Buhr et al., 2007; Chin et al., 2007;
Prowse et al., 2007) and de-cellularized matrices with mass
spectrometry (Abraham et al., 2010). Several ECM proteins
such as collagens, fibronectin, laminins, nidogen and heparan
sulfate proteoglycans have been suggested as key factorsprovided by the hESC-supportive feeder cells (Lim and Bodnar,
2002; Prowse et al., 2005, 2007; Abraham et al., 2010). Vitro-
nectin (Braam et al., 2008; Prowse et al., 2011), fibronectin
(Amit and Itskovitz-Eldor, 2006), laminin (Xu et al., 2001;
Rodin et al., 2010) and a combination of collagen IV, vitronec-
tin, fibronectin, and laminin (Ludwig et al., 2006a), have been
used as substrata in feeder-independent culture of hESCs,
showing that these ECM proteins, in combinations with specif-
ic media and growth factors, support attachment and prolifer-
ation of hESCs.
In addition to ECM proteins, growth factors provided by the
feeder cells or in the culture medium are essential for hESC
growth. The central role of basic fibroblast growth factor
(bFGF) in hESC self-renewal is well established (Dvorak et al.,
2005; Levenstein et al., 2006). Basic FGF and transforming
growth factor beta (TGFß) family members TGFß, activin A
(ActA) and nodal (Vallier et al., 2005; Xiao et al., 2006) co-oper-
ate tomaintain undifferentiated hESC growth. The gene expres-
sion and secretion of these key growth factors have been shown
to differ between hESC-supportive and non-supportive feeder
cells (Eiselleova et al., 2008; Kueh et al., 2006).
In this study, we have compared the hESC-supporting
capacity of in-house derived, hDF feeder cells to the com-
mercial hFF feeder cells in a xeno-free culture system,
based on the use of human serum (HS)-containing culture
medium. We further studied the differences in ECM gene
expression and synthesis and secretion of key growth fac-
tors between these fibroblasts. We found significant differ-
ences in the capacity of the different fibroblast cell lines to
support hESC self-renewal and in the production of distinct
candidate proteins such as laminin-511.
2. Results
2.1. Derivation and culture of xeno-free human der-
mal fibroblastsOur initial goal was to derive xeno-free hDF feeder cells that
could be used for the production of GMP-grade, clinical quality
hESCs. A total of 6 pediatric skin tissue pieces were donated in
context of surgery and 5 cell lines were successfully derived
from the tissues. The methods were extensively optimized to
find simple, effective and eventually GMP-compatible deriva-
tion, culture and cryobanking procedures. Explant culture was
found superior to enzymatic digestion of dermis with collage-
nase, due to simplicity and low cost. HS concentrations from
5% to 20% were tested and 15% HS was found adequate for opti-
mal growth. Heat inactivation (30 min at 56 °C) of HS substan-
tially decreased growth rate and quality of the culture. The
outgrowth of fibroblasts was commonly detected within a
week. The fibroblast growth typically slowed down after 6–7
passages. All five hDF lines were successfully recovered after
cryopreservation.
When used as hESC feeder cells, none of the five hDF lines
could support the undifferentiated state of hESCs. Our routine-
ly used, supportive hFF CRL-2429 line was transferred to iden-
tical HS-based culture system for comparison. On hFF
CRL-2429 the hESCs retained their undifferentiated morpholo-
gy (data not shown) confirming that hESC differentiation was
not caused by the xeno-free feeder cell culture conditions,
Figure 1 Overview of the workflow.
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lines. To further study the factors behind the difference in
hESC supportiveness, we chose the hDF 001/08 line for further
functional studies and compared its performance and charac-
teristics to the hFF CRL-2429 feeder cells. The hESC supporting
capacity of the fibroblasts was first analyzed in depth with two
hESC lines and further the ECM expression profile and key
growth factor secretion of both feeder cell typeswere studied.
An overview of the workflow is presented in Fig. 1.2.2. hFFs provide stable support for undifferentiated
hESC growth in contrast to hDFs
Two independently-derived hESC lines, Regea 07/046 and
Regea 08/017, were cultured on both hFF CRL-2429 and
hDF 001/08 fibroblast feeder cells. The cultures were ana-
lyzed in depth in terms of hESC colony morphology, prolifer-
ation and expression of pluripotency markers on both RNA
and protein level. The hESC colony morphology was marked-
ly different throughout the culture on the two types of feed-
er cells. On the hFF cells, hESC colonies were flat and
smooth with well-defined edges (Fig. 2A). The morphology
remained unchanged through 10 passages, corresponding to
2.5 months of culture and the hESCs were immunoreactive
for Nanog antibody. On hDF 001/08 feeder cells, hESCs
underwent progressive differentiation with corresponding
morphological changes manifested as loss of smooth struc-
ture and defined colony edges (Fig. 2A), and Regea 08/017
and Regea 07/046 hESC lines could be cultured for a maxi-
mum of 8 and 6 passages, respectively, on these feeders be-
fore all colonies had differentiated. The proliferation rate of
the hESCs, as measured by bromodeoxyuridine (BrdU)incorporation assay at passage 1–3, was slightly higher on
hFFs compared to hDF feeders (Fig. 2B).
Differentiation status of the hESCs on both feeder cell
types was analyzed with relative quantitative RT-PCR (q-
PCR) analysis of four pluripotency markers: Nanog, POU5F1,
TDGF, and DNMT3B. In accordance with the morphological
changes, q-PCR analysis showed progressive loss of all
four markers for the hESCs cultured on hDFs compared to
hESCs cultured on hFFs over six passages (Fig. 2C). This was
further confirmed at protein level by flow cytometry analysis
of TRA-1-81 andOCT-3/4 expression. Both hESC lines gave sim-
ilar results, shown for Regea 07/046 (Fig. 2D). Taken together,
the analysis confirmed that the hFFs provided a stable, xeno-
free feeder cell line to support long-term culture of undiffer-
entiated hESCs, whereas hDF feeder cells did not support
hESC self renewal.
2.3. hDFs show significant down-regulation of several
laminin and integrin subunits compared to hFFs
In order to understand the functional differences between the
two feeder cell lines in hESC supportiveness, the hFF CRL-2429
and hDF 001/08 feeder cells were compared for the expression
of 84 ECM and ECM-related protein-coding genes by q-PCR
array analysis. The hDFs were compared to hFFs for the ex-
pression of each gene. Detailed results of this experiment
can be found in Supplementary Table 1. Eighteen genes were
down-regulated at least two fold and 12 genes up-regulated
at least two fold in the hDFs compared to the hFF cells
(Fig. 3A). Laminin subunits α1, α3, ß3 and integrin subunits
α3, α6, α7 were among the down-regulated genes. The ex-
pression of additional laminin chains α4, α5 γ2, and B-CAM in
both feeder cell types was studied by q-PCR. Altogether, the
Figure 2 Characterization of hESCs cultured on hFF CRL-2429 and hDF 001/08 feeder cells. (A) Typical hESC colony morphology and
immunostainings for Nanog in the beginning of culture and after serial passaging. Colonies on hFFs showed undifferentiated morphol-
ogy and stable Nanog expression, whereas on hDFs hESCs differentiated with corresponding changes in morphology and weaker ex-
pression of Nanog. Scale bars 500 μm for phase contrast images and 200 μm for fluorescence images. (B) Cell proliferation analysis
showed higher proliferation rate for hESCs cultured on hFFs compared to those cultured on hDFs (*p=0.003, Mann–Whitney U-
test). (C) Relative q-PCR analysis showed progressive down-regulation of all four pluripotency markers analyzed for hESCs cultured
on hDFs compared to hESCs cultured on hFFs, set as reference=1. The down-regulation of all genes was statistically highly significant
(p-values=0.004, Mann–Whitney U-test). (D) Flow cytometry analysis for hESCs cultured on hFFs and hDFs over 10 passages. hESCs
showed constant expression of both TRA-1-81 and OCT-3/4 on hFFs, but progressive differentiation with decreasing positivity for
both markers on hDFs. End point analysis shown in (E) and (F), black=negative control, blue=isotype control.
100 H. Hongisto et al.laminin subunitsα1,α3,α5 and ß3were significantly (over two
fold) down-regulated in hDFs, indicating lower expression of
laminins −111, −332 and −511. Accordingly, the expression
levels of integrin subunits α3, α6, α7 forming laminin binging
integrins α3ß1, α6ß1, α6ß4, α7ß1 were also significantly
lower in hDF cells. (Fig. 3B and Supplementary Table 2).
Other genes of interest were for example E-cadherin type I
and vitronectin thatwere down-regulated 2.5 and 2.7-fold, re-
spectively in the hDF cells. The largest difference inexpression was for Kallmann syndrome 1 sequence (KAL1),
26-fold lower in hDF than hFF cells (Supplementary Table 1).2.4. Laminin-511 is synthesized by the hFF and mEF
but not by the hDF cells
The production of laminin α5 chain was studied at protein
level. Human ESC-supportive hFF CRL-2429 cells, mEF cells,
Figure 3 (A) Volcano plot for≥2-fold down-regulated (green)
and ≥2-fold up-regulated (red) ECM and related genes for hDF
001/08 compared to hFF CRL-2429 feeder cells analyzed with
RT² Profiler™ PCR Array. Genes above the blue line have a p-
valueb0.05 (Student's t-test, RT² Profiler™ PCR Array Data Anal-
ysis software, SABiosciences). (B) Integrin and laminin subunit
fold regulations for hDFs compared to hFFs analyzed by q-PCR.
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002/06, hDF 003/06, hDF 001/07 and hDF 001/08) were la-
belled over night by 35S-methionine, followed by immuno-
precipitation of the laminin α5 chain from the culture
supernatant. Importantly, laminin α5 chain was synthesized
only by the hESC-supportive hFF and mEF cells but not by
any of the hDF cells (Fig. 4A). In accordance with the immu-
noprecipitation data, indirect immunofluorescence labelling
for laminin α5 showed that the hFFs express laminin α5,
even if not abundantly, where as there was no expression
by any of the hDF lines (Fig. 4B).
2.5. hDFs secrete less TGFß compared to hFFs
The hFF CRL-2429 and hDF 001/08 feeder cells were com-
pared for their secretion of key growth factors bFGF, TGFß
and ActA, known to be important for hESC maintenance.Human ESC culture medium without added exogenous bFGF
was incubated overnight on cultures of both feeder cell
types and analyzed for the secretion of growth factors by en-
zyme-linked immunosorbent assay (ELISA). Both fibroblast
types secreted undetectable amounts of bFGF (data not
shown). They also secreted equal amounts of ActA. After ir-
radiation, the secretion of ActA increased more than two
fold for both feeder cell types (Fig. 5A). In contrast, the
hFF cells secreted 0.6 ng/ml more TGFß than hDF cells
(mean secretion 856 vs. 304 pg/ml; pb0.01) (Fig. 5B). To
test whether the difference in TGFß production by the feed-
er cells affected hESC phenotype, the hESCs were cultured
on hDF 001/08 feeder cells in standard hESC culture medium
containing 8 ng/ml bFGF, supplemented with recombinant
TGFß. The addition of 0.6 ng/ml TGFß did not have a rele-
vant impact on hESC colony morphology or to percent of
TRA-1-81 positive cells in flow cytometry analysis over 6 pas-
sage culture period (Figs. 5 C and D). On the contrary, a
higher concentration of 6.0 ng/ml TGFß rescued the hESC
colony morphology to some extent (Fig. 5C) and increased
the TRA-1-81 positivity of the cells from an average of 51%
to 82% during the short term culture (Fig. 5D).3. Discussion
Feeder cells contribute to maintenance of hESC morphology
and pluripotent status in feeder-dependent culture conditions
by mechanisms that are poorly known. Likely the feeder cells
will be replaced with more defined, feeder-independent
hESC culture conditions in the future. Many serum-free media
formulations for feeder-independent hESC culture have been
published and some, such as mTeSR1 (Stemcell Technologies)
(Ludwig et al., 2006b) and STEMPRO hESC SFM (Life Technolo-
gies, Invitrogen) are commercially available. These media are
routinely used in combination with xeno-derived, undefined
matrices like Matrigel or Geltrex but have been shown to sup-
port pluripotent stem cell culture also with defined substrates
like vitronectin (Braam et al., 2008) and laminin-511 (Rodin
et al., 2010). Although the long-term culture of undifferen-
tiated pluripotent stem cells is possible in these feeder-inde-
pendent conditions, the media still contain undefined and
xeno-derived compounds and the success of deriving new plu-
ripotent stem cell lines, both hESC and hiPSC, in completely
defined, xeno- and feeder-free conditions is low. Defining the
factors provided by fibroblast feeder cells and revealing their
complex mechanisms in hESC maintenance provides valuable
tools for further development of feeder-independent deriva-
tion and culture methods.
We studied the differences in ECM and growth factor pro-
duction between hESC-supportive and non-supportive human
fibroblast feeder cells. Many of the genes down-regulated in
the non-hESC supportive hDF feeder cells were distinct lami-
nin isoforms and laminin related integrin subunits that have
been reported to be associated with undifferentiated hESCs.
Laminins are trimeric glycoproteins consisting of one α (1–
5), one ß (1–3), and one γ (1–3) chain (Colognato and Yurch-
enco, 2000), and are the first ECM proteins synthesized by
the mouse blastocyst (Miner et al., 2004). A number of studies
have shown that in addition to embryogenesis, the specific
laminin isoforms regulate cell adhesion, proliferation, migra-
tion and differentiation (Colognato and Yurchenco, 2000;
Figure 4 Laminin α5 chain production by the hFF, mEF and hDF feeder cell lines. A) The cells were radioactively labelled followed
by immunoprecipitation and SDS-PAGE analysis. hESC-supportive hFF and mEF feeder cells synthesize and secrete laminin α5 chain,
whereas none of the hDF cell lines do. Positive laminin α5 bands shown by arrows. JAR=positive control cells. -Ab: no primary anti-
body, negative control precipitation. B) Indirect immunofluorescence staining with monoclonal antibody specific for human laminin
α5 chain confirms that hFF cells synthesize laminin α5 (white arrow). The hDF lines show no laminin α5 expression. Lower panel shows
the negative control stainings carried out without primary antibody (No MAb). 40× magnification.
102 H. Hongisto et al.Scheele et al., 2007). We have previously shown that undiffer-
entiated hESCs synthesize and deposit laminin-511 (α5ß1γ1)
and -111 (α1ß1γ1) and that laminin-511, purified from
human cells, can be used as a supportive matrix in feeder-in-
dependent hESC cultures (Vuoristo et al., 2009). These results
have been confirmed by others for both hESCs (Rodin et al.,
2010; Miyazaki et al., 2008; Evseenko et al., 2009) and
mESCs (Domogatskaya et al., 2008), indicating that laminin-
511 has a central role in the maintenance of hESC survival
and pluripotency. Some studies have also reported laminin-
332 (α3ß3γ2) to function as hESC substrata (Miyazaki et al.,
2008). In the present study, laminin-511 was found to be pro-
duced by the most commonly used hESC-supportive feeder
types, hFFs andmEFs, but not by the non-supportive hDF feed-
er cell lines. This indicates that laminin-511 might also act in
hESC self-renewal through feeder cells, yet the possiblemech-
anism remains to be studied.
The cell interactions to laminins as well as other ECM pro-
teins are mediated mainly through integrins, heterodimeric
cell membrane receptors of one α (1–18) and one ß (1–8)
subunit (Hynes, 2002). Human ESCs synthesize several integ-
rin subunits: at least α3, α5, α6, α7, αV, ß1, ß5 and interac-
tion with the hESC-critical laminins is mediated through
integrins α6ß1 and α3ß1 and Lutheran/B-CAM receptor, an
Ig-superfamily member (Xu et al., 2001; Rodin et al., 2010;
Vuoristo et al., 2009; Miyazaki et al., 2008; Evseenko
et al., 2009). In our study, the integrin subunits α3, α6 and
α7 forming the laminin-binging integrins α3ß1, α6ß1, α6ß4,
α7ß1, were down-regulated in the hDFs as compared tohFF cells. Given that hESCs, as well as hFFs, produce lami-
nins-111 and -511, we suggest that the hFF feeder cells sup-
port hESCs, at least in part, due to ideal laminin synthesis
and the presence of the appropriate set of laminin-binding
receptors. Taken together, our results suggest that the in-
terplay between hFFs and hESCs likely depends on crucial
signals originating from the ECM environment provided by
the feeders.
In addition to genes coding for laminins and integrins,
other interesting genes showed lower expression in non-
hESC-supportive hDF feeder cells. One of them was the
gene coding for vitronectin. Vitronectin has been suggested
as one of the defined matrix alternatives to Matrigel in
feeder-independent hESC cultures (Braam et al., 2008). Ac-
cordingly, a recombinant, functional N-terminal domain of
vitronectin has been shown to enable long-term feeder-inde-
pendent hESC cultures (Prowse et al., 2010). Vitronectin
binds to insulin-like growth factor (IGF) receptors (Kricker
et al., 2003) that promote hESC survival and pluripotency
(Bendall et al., 2007; Wang et al., 2007). Vitronectin-
IGF-I function in hESC cultures is evident from a recent
study showing that a synthetic vitronectin/IGF-I protein
supports long-term hESC culture in the absence of feeder
cells and serum (Manton et al., 2010).
Another receptor of interest, E-cadherin type I, was also
down-regulated in hDF cells. E-cadherin-mediated cell–cell ad-
hesion and signaling are essential for the colony formation and
self-renewal of hESCs (Li et al., 2010; Xu et al., 2010) and a re-
combinant E-cadherin substratum has been used for feeder-
Figure 5 Growth factor secretion analyses of hFF and hDF feeder cells on day 4 to 7 after irradiation. (A) No statistical difference in
average secretion of ActA between the two feeder cells. (B) hFFs secreted in average 0.6 ng/ml more TGFß compared to hDFs. The
difference was statistically highly significant (pb0.01, Mann–Whitney U-test). The Knockout Serum Replacement (ko-SR) was mea-
sured to contain 315 pg/ml TGFß and hESC medium (20% ko-SR) thus calculated to contain approximately 63 pg/ml TGFß, marked
in the picture with a black line. (C) hESC colony morphology after 5 passages of TGFß supplementation to culture on hDFs. Addition
of 0.6 ng/ml TGFß did not rescue hESC colony morphology, whereas 6.0 ng/ml TGFß resulted in more compact colonies with improved
morphology. Scale bars 500 μm. (D) Flow cytometry analyses during TGFß supplementation at passages 2–6. Average percent of TRA-
1-81 positive hESCs cultured on hFFs in hESC medium and on hDFs in hESC medium as well as in hESC medium supplemented with TGFß
are shown.
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2010). Moreover, it has been postulated that E-cadherin
-based cell contacts are stabilized by laminin-binding integrins
possibly binding these two factors together in hESC signalling
(Stipp, 2010). Surprisingly, KAL1 gene coding for Anosmin-1,
was down-regulated 26-fold in hDF cells. Anosmin-1 enhances
FGF signaling via regulation of bFGF/FGF receptor-1
(FGFR1)/heparin signaling-complex assembly and activity (Hu
et al., 2009). Anosmin-1 could thus play a role in maintaining
a sufficient level of bFGF signaling in the hESCs.
Neither of the fibroblast feeder cell types secreted de-
tectable amounts of bFGF in our ELISA analysis. In another
study, hESC-supportive human fetal skin feeder cells have
shown 3-fold up- regulation of bFGF compared to non-
hESC supportive fetal feeder cells. However, only RNAlevels were measured (Kueh et al., 2006). In a study com-
paring growth factor secretion of different fibroblast feed-
er cells by ELISA, the hFFs were found to secrete a few
pg/ml bFGF, and also ActA with similar levels to our
study (Eiselleova et al., 2008). The small discrepancies in
the results are likely due to differing fibroblast culture
and experimental conditions. The hESC-supportive hFF
feeder cells were found to secrete more TGFß than the
hDF feeder cells, but the addition of the same concentra-
tion of recombinant TGFß to hESC culture on hDFs did not
rescue colony morphology or the level of TRA-1-81 expres-
sion. Partial rescue of hESC colony morphology and expres-
sion of TRA-1-81 near the level of hESC culture on hFFs,
required a six times a week supplementation with tenfold
concentration (6.0 ng/ml) of recombinant TGFß. It is thus
104 H. Hongisto et al.unlikely that the difference between the feeder cells
would derive from the difference in secretion of TGFß.
We conclude, that we have established xeno-free fibro-
blast feeder cell lines using HS-containing culture medium
and, in accordance with published data agree, that HS
is a feasible substitute for FBS (Richards et al., 2003;
Kibschull et al., 2011; Ellerstrom et al., 2006; Meng
et al., 2008; Unger et al., 2008). We found several differ-
ences between xeno-free hESC-supportive and non-sup-
portive feeder cells. We show that hESC-supportive
feeder cells produce laminin-511, which may contribute
to maintenance of hESC pluripotency. Our study also sug-
gests that vitronectin and E-cadherin type I, both with
known function in hESC biology, are likely to also have
roles in feeder-dependent maintenance of pluripotency.
Kallmann syndrome 1 sequence, coding for Anosmin-1, a
known regulator of FGF signalling, is a novel candidate fac-
tor associated with hESC pluripotency through feeder cell
culture. These findings provide clues for the development
of defined culture conditions for human pluripotent stem
cells.4. Materials and methods
4.1. Cell lines and cell culture
4.1.1. Derivation and culture of xeno-free fibroblasts
Five hDF cell lines: hDF 001/06, hDF 002/06, hDF 003/06, hDF
001/07, hDF 001/08 were derived from dermal tissues obtained
from children under the age of 1 year in context of surgery. The
tissues were donated with informed consent of voluntary par-
ents, and the project had a supportive statement of the Ethics
Committee of Pirkanmaa Hospital District (R05149). The fibro-
blast cell lines were derived as explant cultures similarly to pre-
viously published protocol (Takashima, 2001). Briefly, the tissue
pieces were extensively washed with PBS (Lonza Group Ltd.,
Basel, Switzerland), subcutaneous tissue and epidermis were
manually removed and dermis cut into 1 mm2 pieces, placed
on tissue culture dishes (Nalge Nunc International, Rochester,
NY, USA) and covered with coverslips (Menzel-Gläser, Braun-
schweig, Germany). Culture medium (HS-medium) consisted
of Iscove's Modified Dulbecco's Medium (IMDM)with L-Glutamine
and 25 mMHEPES (Invitrogen Carlsbad, CA, USA), supplemented
with 15% human serum (Type AB, PAA Laboratories GmbH
Pasching Austria) and 0.5% Penicillin/streptomycin (Cambrex
Bio Science, Walkersville, MD, USA). Human DF were cultured
at 37 °C, 5% CO2, monitored daily for fibroblast outgrowth
with Nikon Eclipse TE2000-S phase contrast microscope (Nikon
Instruments Europe B.V. Amstelveen, The Netherlands), and
the culture medium was changed every 3–4 days. Upon con-
fluency the fibroblasts were harvested and passaged with
xeno-free, recombinant TrypLE Select (Invitrogen). Cells we
cryopreserved at early passages in HS-medium supplemented
with 5–10% Dimethyl sulfoxide (DMSO, Sigma-Aldrich).
Human FF cells (CRL-2429) were purchased as a frozen
stock (American Type Culture Collection, ATCC, Manassas,
VA, USA) and thawn to HS-medium at passage level 5. The
cell line was cultured up to passage level 13 and cryopre-
served during the early passages in HS-medium supplemen-
ted with 5% DMSO. The hFFs were cultured in HS-medium
and passaged with TrypLE Select similarly to hDFs.Mouse EF cells were derived from pc ICR fetuses and cul-
tured in 10% fetal bovine serum and 1X Glutamax in Dulbec-
co's Modified Eagle medium (all reagents from Invitrogen).
4.1.2. Human embryonic stem cell lines
The two hESC lines used in this study, Regea 07/046 and Regea
08/017, were derived in Regea – Institute for Regenerative
Medicine, University of Tampere, Finland. Both hESC lines
were derived on hFF (CRL-2429) feeder cells and cultured
and characterized as previously described (Skottman, 2010).
Regea has approval of National Authority for Medicolegal Af-
fairs Finland to study human embryos (Dnro1426/32/300/05)
and a supportive statement of the Ethics Committee of Pirkan-
maa Hospital District for the derivation, characterization, and
differentiation of hESC lines (Skottman/R05116).
4.1.3. Human embryonic stem cell culture on hFFs and
hDFs
For the use as hESC feeder cells, the fibroblasts were inacti-
vated by gamma irradiation (40 Gy), and 3.65×104 cells/cm2
were plated to culture dishes (Corning Incorporated, NY,
USA). On day one after inactivation, adaptation to serum-
free culture was performed by adding half HS-medium and
half hESC medium. On day two, hESC medium was changed
and hESCs were manually passaged on to the feeder cells.
The hESC culture medium consisted of Knockout-Dulbecco's
Modified Eagle's Medium (ko-DMEM) supplemented with 20%
Knockout Serum Replacement (ko-SR), 2 mM GlutaMax (all
from Invitrogen), 1% MEM Eagle Non-Essential Amino acid solu-
tion (NEAA, Cambrex Bio Science), 50 U/ml penicillin/strepto-
mycin (Cambrex Bio Science), 0.1 mM ß-mercaptoethanol
(Invitrogen) and 8 ng/ml bFGF (R&D Systems Minneapolis,
MN, USA). For the testing of the influence of TGFß on hESC
phenotype on hDF 001/08 feeder cells, recombinant human
TGFß1 (PeproTech, London, UK) was added to parallel cul-
tures of Regea 07/046 in hESC medium containing 8 ng/ml
bFGF. TGFß concentrations of 0.6 ng/ml and 6.0 ng/ml were
tested. Human ESCs were cultured andmonitored as described
above and culture medium was changed six times a week.
Undifferentiated hESC colonies were manually passaged
every 6 to 7 days onto new inactivated feeder cells.
4.2. Immunofluorescence
Regea 08/017 hESCs cultured on hFF CRL-2429 and hDF 001/08
were labelled with 1:200 dilution of anti-human Nanog antibody
(R&D Systems) as described previously (Hakala et al., 2009). For
laminin α5 chain immunofluorescence, hFF and hDF fibroblasts
were cultured on 0.01% poly-L-lysine (Sigma-Aldrich) coated
glass slides (BD Falcon) and fixed by 4% paraformaldehyde
(PFA) (Sigma-Aldrich), for 15 min at room temperature (RT).
The samples were washed by PBS, treated with 0.5% Triton X-
100 in PBS for 5 min and blocked by Ultra V block solution (Ther-
mofisher Scientific, Waltham, MA) for 10 min. All steps were
performed at RT. The samples were incubated over night in
the presence of the monoclonal antibody (clone 4C7) specific
for human laminin α5 chain. After careful washing of the un-
bound antibody, the samples were incubated for 30 min with
goat anti-mouse IgG AlexaFluor 488 that was diluted 1:500 in
0.1% Tween-PBS, at RT, in dark. Finally, the specimens were
embedded in Vectashield Mounting Medium for fluorescence
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ages were acquired by Axioplan 2 fluorescence microscope,
using Axiovision 4.8 software (Carl Zeiss Light Microscopy, Göt-
tingen, Germany).4.3. Cell proliferation assay
Cell proliferation of Regea 08/017 hESCs cultured on hFF
CRL-2429 and hDF 001/08 feeder cells was determined
using colorimetric immunoassay (Cell Proliferation ELISA
BrdU, Roche Diagnostics GmbH, Mannheim, Germany)
based on the measurement of BrdU incorporation during
DNA synthesis. The hESC colonies were incubated overnight
at 37 °C with 2× BrdU Labeling reagent, detached with
TrypLE Select to single-cell suspension from the feeder
cells and 1×104 cells/well distributed to flat bottom 96-well
plate (Nunc) with 8 replicates of each sample. The assay was
performed according to manufacturer's instructions. The ab-
sorbance was measured at 450 nm with Viktor 1429 Multilabel
Counter (PerkinElmer-Wallace, Norton, OH, USA). Cells with-
out BrdU labelling were used as a background control. Inacti-
vated fibroblasts alone were controlled for not incorporating
BrdU. The analysis was repeated for a total of 4 times for
hESCs on day 3, day 4 and day 5 after passaging at passage
levels 1–3. The results were pooled and mean absorbance
for background control was subtracted from the absorbance
values. Pasw statistics 18 software and Mann–Whitney U-test
were used to determine statistical difference between mean
hESC proliferation rates on the two feeder types. p-values
b0.05 and b0.01 were considered statistically significant and
highly significant, respectively.4.4. Flow cytometry
The hESC cultured on hFF CRL-2429 and hDF 001/08 were an-
alyzed by flow cytometry for TRA-1-81 and OCT-3/4 expres-
sion at passages 1–6, 8 and 10. For hESCs cultured on hDF
001/08 flow cytometry analysis was conducted until the col-
onies had differentiated completely and no further passaging
was feasible. Where TGFß growth factor was added to hDF
001/08 culture, the cells were analyzed for TRA-1-81 expres-
sion during passages 2–6. All hESC colonies without selection
were collected for analysis and detached from the feeder
cells to a single-cell suspension with TrypLE Select. For
TRA-1-81 labelling, 0.1×106 cells/sample were probed
with 8 μl FITC Mouse anti-Human TRA-1-81 (Becton Dickin-
son, Franklin Lakes, NJ, USA) for 30 min at 4 °C in 0.5%
BSA (Sigma-Aldrich) and 0.01% NaN3 (Sigma-Aldrich) in
PBS. For OCT-3/4 labelling cells were fixed with 4% PFA for
10 min at RT and probed with 10 μl Anti-human OCT-3/4-
Fluorescein Monoclonal Antibody (R&D Systems) for 30 min
at RT in 0.1% Saponin (Sigma-Aldrich) and 0.05% NaN3 in
PBS. The cells were analyzed using BD FACSAria (Becton
Dickinson). The acquisition was set for 10,000 events per
sample. PE-conjugated Goat F(ab´)2 Anti-Mouse IgG (Caltag
Laboratories, Burlingame, CA, USA) and FITC Mouse IgM
(Becton Dickinson) were used as isotype controls. The
data were analyzed using FACSDiva Software version 4.1.2
(Becton Dickinson).4.5. Q-PCR
4.5.1. Analysis of pluripotency marker expression of
hESCs
Regea 07/046 hESCs cultured on hFF CRL-2429 and hDF
001/08 were analyzed for the expression of pluripotency
genes POU5F1 (OCT-3/4), NANOG, DNMTB3 and TDGF1 with
q-PCR at passages 1–6 until complete hESC differentiation
on hDF 001/08. All hESC colonies without any selection
were manually cut off and collected for analysis.
The RNA was extracted with Qiagen RNeasy Plus Mini kit
(Qiagen, Valencia, CA, USA) according to manufacturer's in-
structions. The RNA concentration and quality were assessed
with NanoDrop 1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA). 200 ng of RNA was
translated to cDNA with High-Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA, USA)
according to manufacturer's instructions. The expression of
the pluripotency genes were analyzed using Taqman gene ex-
pression assays (Applied Biosystems): Nanog (Hs02387400_g1),
POU5F1 (Hs00999632_g1), TDGF1 (Hs02339496_g1) and
DNMT3B (Hs01003405_m1). GAPDH (Hs99999905_m1) was used
as a housekeeping control. The PCR reaction consisted of 3 μl
of cDNA in 1:100 dilution, 7.5 μl of 2× TaqMan Universal PCR
Master Mix (Applied Biosystems), 0.75 μl of assay and 3.75 μl
of H2O. All samples and no template controls were analyzed as
three replicates. The q-PCRwas carried out with Applied Biosys-
tems 7300 Real-time PCR system: 2 min at 50 °C, 10 min at
95 °C, and 40 cycles of 15 s at 95 °C and 1 min at 60 °C.
The data was analyzed with 7300 System SDS Software (Ap-
plied Biosystems) and Microsoft Office Excel 2003 (Microsoft
Corporation, Redmond, WA, USA). Relative quantification
was calculatedwith the −2ΔΔCt method (Livak and Schmittgen,
2001). The data was normalized to the expression of GAPDH
and the expression levels of Regea 07/046 cultured on hFF
were used as reference level at each passage (fold change=1).
The data is presented as fold regulation values for better visu-
alization of down-regulation: for fold change values greater
than one, fold regulation is equal to fold change. For fold
change values less than one, fold regulation is the negative in-
verse of the fold-change, calculated as −1/(fold change).
Standard deviation of the 3 replicate fold change values is pre-
sented as error bars. For determining statistical significance,
the mean fold regulation during the six culture passages on
both feeder types was compared using the Mann–Whitney U-
test.4.5.2. ECM profiling of hFF and hDF fibroblasts
For the comparison of the ECM profiles of the feeder cells,
three biological replicates of both fibroblast types: hFF
CRL-2429 at passages 9, 10 and 11 and hDF001/08 at pas-
sages 3, 4 and 5 were used for analysis. Feeder cells were
prepared by γ-irradiation according to normal protocol.
Cells were lysed for RNA extraction at day 3 post irradiation.
The RNA was extracted with Qiagen RNeasy Plus Mini kit
(Qiagen) according to manufacturer's instructions and con-
centrations assessed with NanoDrop 1000 spectrophotome-
ter (NanoDrop Technologies). One μg of RNA from each
sample was translated to cDNA with RT2 First Strand Kit
(SABiosciences, MD, USA) according to manufacturer's in-
structions. The cDNA was loaded to RT2 ProfilerTM PCR
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array (PAHS-013A) according to manufacturer's instructions.
All reagents were bought from SABiosciences. The q-PCR
was carried out with Applied Biosystems 7300 Real-time
PCR system: 10 min at 95 °C, 40×15 s at 95 °C and 1 min at
60 °C, followed by the melting curve program: 15 s at
95 °C; 1 min at 60 °C; 15 s at 95 °C; 15 s at 60 °C.
The data was analyzed with RT² Profiler™ PCR Array Data
Analysis software (http://www.sabiosciences.com/pcr/
arrayanalysis.php) using the -2ΔΔCt -based fold-change calcu-
lations and normalizing the data with the expression of the
housekeeping genes Beta-2-microglobulin (B2M), Hypoxan-
thine phosphoribosyltransferase 1 (HPRT1), Ribosomal protein
L13a (RPL13A), Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and Actin, beta (ACTB). The expression levels of
hFF CRL-2429 were used as reference level for each gene.
Fold regulation was calculated as described above. Statistical
analysis (Student'st-test) was conducted by the software.
4.5.3. Analysis of laminin subunit α4, α5, γ2 and B-CAM
expression of hFF and hDF fibroblasts
Human FF CRL-2429 (passages 9, 10 and 11) and hDF001/08
(passages 3, 4 and 5) feeder cells were additionally analyzed
for laminin chain α4, α5, γ2 and B-CAM expression with Taq-
man gene expression assays: LAMA4, Hs00158588_m1;
LAMA5, Hs00245699_m1; LAMC2, Hs01043711_m1; BCAM,
Hs00170663_m1. GAPDH (Hs99999905_m1) was used as a
housekeeping control. RNA extraction, cDNA synthesis and q-
PCR reactions were conducted as described above in 4.5.1.,
except 1:5 dilution of cDNA was used for the q-PCR reactions.
Expression levels of hFF CRL-2429 were used as reference
level.
4.6. Radioactive, metabolic labelling and immuno-
precipitation of the culture media
The metabolic labelling, sample preparation and detection
were performed as described in detail in (Vuoristo et al.,
2009). Briefly, 100 μCi of 35S-labelled methionine was
added to the methionine-deprived culture medium and incu-
bated overnight. The labelled culture media were collected,
preabsorbed with GammaBindSepharoseBeads and then
absorbed over night with GammaBindSepharoseBeads pre-
coupled with antibodies directed to laminin α5 chains. In
case of human fibroblasts, we used mAB, clone 4 C7, direct-
ed against human laminin α5 chain and in case of mEFs, we
used pc antibody, clone 1121, that recognizes mouse lami-
nin-511 (the latter was a kind gift from Dr. Takako Sasaki).
After an overnight immunoprecipitation, the bound proteins
were washed, eluted to Laemmli's buffer and analyzed by
SDS-PAGE. JAR choriocarcinoma cells (HTB-144, ATCC) syn-
thesizing laminin-511 were used as positive control cell
line. For the negative control precipitations, the antibody
was omitted.
4.7. Growth factor secretion analysis
Human FF CRL-2429 and hDF 001/08 feeder cell CM were an-
alyzed for bFGF, ActA and TGFß growth factor secretion with
enzyme-linked immunosorbent assay (ELISA). The feedercells were prepared by irradiation as described above. On
days 4–7 post inactivation, 0.2 ml/cm2 of hESC medium
without bFGF was collected daily after overnight incubation
on the feeder cells and stored at −70 °C prior the ELISA anal-
ysis. Following ELISA kits were used: Quantikine Human FGF
basic Immunoassay (DFB50), Quantikine Human TGF-ß1 Im-
munoassay (DB100B) and Quantikine Human/Mouse/Rat
Activin A Immunoassay (DAC00B), all from R&D Systems. CM
were analyzed according to manufacturer's instructions. All
media samples were analyzed as duplicates and measure-
ments repeated twice with similar results. Mann–Whitney
U-test was used for statistical analysis.Supplementary materials related to this article can be
found online at doi: 10.1016/j.scr.2011.08.005.
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